SYNERON MEDICAL LTD - ORD SHS (ELOS)

CUSIP: M87245102

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class
Equity / ORD SHS
Total 13F shares
26,016,351
Share change
+239,399
Total reported value
$276,296,314
Price per share
$10.62
Number of holders
76
Value change
+$2,074,455
Number of buys
33
Number of sells
36

Quarterly Holders Quick Answers

What is CUSIP M87245102?
CUSIP M87245102 identifies ELOS - SYNERON MEDICAL LTD - ORD SHS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SYNERON MEDICAL LTD - ORD SHS (ELOS) as of Q2 2015

As of 30 Jun 2015, SYNERON MEDICAL LTD - ORD SHS (ELOS) was held by 76 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 26,016,351 shares. The largest 10 holders included Senvest Management, LLC, NORTH TIDE CAPITAL, LLC, JPMORGAN CHASE & CO, DEERFIELD MANAGEMENT CO, DALTON GREINER HARTMAN MAHER & CO, SENZAR ASSET MANAGEMENT, LLC, Broadfin Capital, LLC, Visium Asset Management, LP, RENAISSANCE TECHNOLOGIES LLC, and GRANAHAN INVESTMENT MANAGEMENT INC/MA. This page lists 76 institutional shareholders reporting positions in this security for the Q2 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.